一種免疫系統(tǒng)功能檢測(cè)的細(xì)胞學(xué)分析方法，只要使用一滴血液就能夠測(cè)定移植患者的免疫功能。該檢測(cè)允許醫(yī)生對(duì)患者使用個(gè)體化的免疫抑制治療方法，以防止器官排斥反應(yīng)，同時(shí)避免感染。

ImmuKnow是Cylex公司(Columbia, MD, USA)的產(chǎn)品，當(dāng)前在許多美國(guó)醫(yī)院和診所配備在患者治療方案之中。它是一種標(biāo)準(zhǔn)化的細(xì)胞學(xué)檢測(cè)方法，能夠十分方便的在實(shí)驗(yàn)室中進(jìn)行，能夠快速而準(zhǔn)確的得到檢測(cè)結(jié)果。通過(guò)最佳化的治療，該檢測(cè)能夠幫助醫(yī)生降低治療成本，減少藥物副作用，提高患者的遠(yuǎn)期生活質(zhì)量。

 
Cellular Assay Guides Post-Transplant Therapy
 
A cellular assay of immune system function using a single drop of blood measures the vitality of a transplant patient’s immune status. The assay allows doctors to tailor individual transplant patient immunosuppressant regimens to prevent organ rejection while avoiding infection.

ImmuKnow, a Cylex (Columbia, MD, USA) product, is currently incorporated into patient protocols at many U.S. hospitals and clinics. It is a standardized cellular assay, easily performed in the lab, with quick and accurate results. By optimizing therapy, the assay helps physicians lower the cost of treatment, reduce side-effects of drugs, and enhance patients’ prospects for long-term quality of life.